Real‐world retrospective study in elderly patients aged 65 years and older with type 2 diabetes mellitus treated with daily oral semaglutide ( <scp>SEMA</scp> ‐elderly)
Oral semaglutide effectively improves glycaemic control and weight management in elderly patients with T2DM while improving lipid and cardiovascular parameters and proving to be safe and well tolerated.
Authors
- Concetta Nadia Aricò
- Paolo Falasca
- Sonia Barraco
- Giovanni Carbotta (ORCID: https://orcid.org/0000-0003-1348-3489)
- Alessandra Barucca
- Vincenzo G. Fiore (ORCID: https://orcid.org/0000-0002-4865-5482)
Institutions
- Azienda Sanitaria Locale Roma 3 (IT)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-01-10
- DOI
- https://doi.org/10.1111/dom.16174
- Citations
- 8
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.36
Funders
- Novo Nordisk